Teladoc Health, Inc. - Common Stock, par value $0.001 per share (TDOC) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2015 to Q4 2025

Type / Class
Equity / Common Stock, par value $0.001 per share
Symbol
TDOC on NYSE
Shares outstanding
175,611,455
Price per share
$7.00
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
123,257,085
Total reported value
$953,076,516
% of total 13F portfolios
0%
Share change
-4,509,266
Value change
-$43,926,960
Number of holders
345
Price from insider filings
$7.00
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Teladoc Health, Inc. - Common Stock, par value $0.001 per share (TDOC) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
VANGUARD GROUP INC 12% $160,164,742 21,018,995 The Vanguard Group 30 Jun 2025
BlackRock, Inc. 7.8% $106,824,046 13,556,351 BlackRock, Inc. 31 Mar 2025
Point72 Asset Management, L.P. 3.3% -34% $44,796,726 -$23,430,960 5,795,178 -34% Point72 Asset Management, L.P. 30 Sep 2025

As of 30 Sep 2025, 345 institutional investors reported holding 123,257,085 shares of Teladoc Health, Inc. - Common Stock, par value $0.001 per share (TDOC). This represents 70% of the company’s total 175,611,455 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Teladoc Health, Inc. - Common Stock, par value $0.001 per share (TDOC) together control 54% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
VANGUARD GROUP INC 12% 21,910,950 +4.2% 0% $169,371,644
BlackRock, Inc. 7.9% 13,878,254 +0.31% 0% $107,278,903
RENAISSANCE TECHNOLOGIES LLC 4.7% 8,176,842 +12% 0.08% $63,206,989
DIMENSIONAL FUND ADVISORS LP 3.9% 6,889,194 +24% 0.01% $53,260,110
Point72 Asset Management, L.P. 3.3% 5,763,342 -26% 0.1% $44,550,635
STATE STREET CORP 2.7% 4,659,892 -6.4% 0% $36,020,965
GEODE CAPITAL MANAGEMENT, LLC 2.4% 4,169,919 +0.48% 0% $32,238,443
MORGAN STANLEY 2.1% 3,600,271 +84% 0% $27,830,104
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 1.4% 2,542,051 -3.8% 0% $19,650,054
GOLDMAN SACHS GROUP INC 1.4% 2,522,994 -3% 0% $19,502,744
AMERIPRISE FINANCIAL INC 1.3% 2,284,697 +11% 0% $17,660,705
Nuveen, LLC 1.1% 1,917,422 +58% 0% $14,821,672
NORTHERN TRUST CORP 1% 1,817,911 +0.04% 0% $14,052,452
Allianz Asset Management GmbH 0.92% 1,619,391 +189% 0.02% $12,517,892
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.86% 1,511,111 -26% 0.02% $11,680,888
TWO SIGMA ADVISERS, LP 0.82% 1,439,617 -49% 0.02% $11,128,239
TANG CAPITAL MANAGEMENT LLC 0.8% 1,400,000 0% 0.42% $10,822,000
Invenomic Capital Management LP 0.78% 1,372,977 -5.1% 0.56% $10,613,112
BRIDGEWAY CAPITAL MANAGEMENT, LLC 0.71% 1,251,776 +25% 0.21% $9,676,228
CITADEL ADVISORS LLC 0.69% 1,218,205 +33% 0.01% $9,416,725
UBS Group AG 0.68% 1,201,784 +20% 0% $9,289,791
TWO SIGMA INVESTMENTS, LP 0.64% 1,131,668 -48% 0.01% $8,747,794
Quantinno Capital Management LP 0.63% 1,111,957 +86% 0.02% $8,595,434
JANE STREET GROUP, LLC 0.62% 1,081,326 +382% 0.01% $8,358,650
JUPITER ASSET MANAGEMENT LTD 0.56% 980,068 0.07% $7,575,926

Institutional Holders of Teladoc Health, Inc. - Common Stock, par value $0.001 per share (TDOC) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 1,876,843 $13,156,475 +$6,564,184 $7.00 33
2025 Q3 123,257,085 $953,076,516 -$43,926,960 $7.73 345
2025 Q2 127,657,050 $1,111,810,150 +$28,908,075 $8.71 348
2025 Q1 124,763,053 $993,126,450 -$13,210,229 $7.96 367
2024 Q4 126,578,660 $1,150,715,617 +$5,539,912 $9.09 364
2024 Q3 125,342,483 $1,150,228,771 -$100,859,113 $9.18 354
2024 Q2 138,617,633 $1,355,753,429 +$85,950,366 $9.78 389
2024 Q1 129,054,882 $1,947,842,480 +$10,838,890 $15.10 410
2023 Q4 140,727 $3,036,324 +$1,948,400 $21.58 4
2023 Q3 120,199,310 $2,234,292,029 -$121,396,375 $18.59 408
2023 Q2 127,022,393 $3,216,271,143 -$236,666,021 $25.32 410
2023 Q1 135,977,210 $3,518,680,088 +$69,010,805 $25.90 407
2022 Q4 134,610,584 $3,183,390,427 -$83,513,576 $23.65 409
2022 Q3 137,614,303 $3,492,597,576 -$105,102,768 $25.35 408
2022 Q2 141,223,653 $4,702,694,015 +$65,612,270 $33.21 474
2022 Q1 138,396,978 $9,984,607,487 -$41,870,125 $72.13 623
2021 Q4 139,024,370 $12,773,693,724 -$124,231,789 $91.82 674
2021 Q3 132,889,507 $16,853,553,345 +$645,101,645 $126.81 731
2021 Q2 127,194,235 $21,168,231,412 +$999,534,359 $166.29 804
2021 Q1 121,126,183 $22,012,348,244 +$1,072,735,934 $181.75 861
2020 Q4 99,602,267 $19,914,335,208 +$5,926,918,005 $199.96 853
2020 Q3 75,500,303 $16,542,105,508 +$917,730,488 $219.24 722
2020 Q2 68,014,701 $12,985,756,643 -$206,346,344 $190.84 644
2020 Q1 72,682,730 $11,271,650,938 -$2,133,678,580 $155.01 552
2019 Q4 86,532,538 $7,244,239,417 -$315,185,290 $83.72 399
2019 Q3 90,781,827 $6,146,494,198 +$308,483,097 $67.72 361
2019 Q2 86,235,505 $5,705,096,962 +$229,301,575 $66.41 354
2019 Q1 84,252,257 $4,684,613,324 +$195,971,834 $55.60 351
2018 Q4 81,494,874 $4,039,354,197 +$66,033,616 $49.57 316
2018 Q3 78,523,577 $6,780,068,511 +$277,524,681 $86.35 327
2018 Q2 75,861,830 $4,403,883,501 -$62,347,356 $58.05 270
2018 Q1 77,108,237 $3,104,445,226 +$70,253,871 $40.30 227
2017 Q4 75,616,458 $2,633,579,497 +$299,133,982 $34.85 202
2017 Q3 65,338,152 $2,166,321,961 +$268,089,183 $33.15 176
2017 Q2 57,277,328 $1,987,730,272 +$287,707,143 $34.70 163
2017 Q1 50,322,095 $1,258,063,925 +$614,467,142 $25.00 128
2016 Q4 28,818,430 $475,514,658 +$62,340,805 $16.50 107
2016 Q3 24,591,861 $450,136,800 +$92,857,950 $18.31 101
2016 Q2 18,481,530 $296,066,335 +$65,131,770 $16.02 84
2016 Q1 15,663,992 $150,727,000 -$36,664,421 $9.60 76
2015 Q4 18,650,348 $334,951,386 -$60,380,024 $17.96 73
2015 Q3 20,870,768 $457,767,253 +$451,432,351 $22.29 88
2015 Q2 266,265 $5,009,000 +$5,009,001 $19.00 14